SK17892000A3 - Poly(adp-ribzo)polymerzov gny - Google Patents

Poly(adp-ribzo)polymerzov gny Download PDF

Info

Publication number
SK17892000A3
SK17892000A3 SK1789-2000A SK17892000A SK17892000A3 SK 17892000 A3 SK17892000 A3 SK 17892000A3 SK 17892000 A SK17892000 A SK 17892000A SK 17892000 A3 SK17892000 A3 SK 17892000A3
Authority
SK
Slovakia
Prior art keywords
parp
leu
glu
lys
ser
Prior art date
Application number
SK1789-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Michael Kock
Thomas H�GER
Burkhard Kr�Ger
Bernd Otterbach
Wilfried Lubisch
Hans-Georg Lemaire
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of SK17892000A3 publication Critical patent/SK17892000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1077Pentosyltransferases (2.4.2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/02Pentosyltransferases (2.4.2)
    • C12Y204/0203NAD+ ADP-ribosyltransferase (2.4.2.30), i.e. tankyrase or poly(ADP-ribose) polymerase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91091Glycosyltransferases (2.4)
    • G01N2333/91142Pentosyltransferases (2.4.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1789-2000A 1998-06-05 1999-06-04 Poly(adp-ribzo)polymerzov gny SK17892000A3 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19825213 1998-06-05
DE19908837 1999-03-01
PCT/EP1999/003889 WO1999064572A2 (de) 1998-06-05 1999-06-04 Poly(adp-ribose) polymerase-gene

Publications (1)

Publication Number Publication Date
SK17892000A3 true SK17892000A3 (sk) 2001-09-11

Family

ID=26046644

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1789-2000A SK17892000A3 (sk) 1998-06-05 1999-06-04 Poly(adp-ribzo)polymerzov gny

Country Status (24)

Country Link
US (3) US7754459B1 (no)
EP (1) EP1082416B1 (no)
JP (1) JP2002517231A (no)
KR (1) KR20010052582A (no)
CN (1) CN1304446A (no)
AR (1) AR020326A1 (no)
AT (1) ATE358175T1 (no)
AU (1) AU4605999A (no)
BG (1) BG105018A (no)
BR (1) BR9910967A (no)
CA (1) CA2330206C (no)
CO (1) CO5070700A1 (no)
DE (1) DE59914280D1 (no)
ES (1) ES2285842T3 (no)
HK (1) HK1038591A1 (no)
HR (1) HRP20010013A2 (no)
HU (1) HUP0103190A2 (no)
ID (1) ID27819A (no)
IL (1) IL139750A0 (no)
NO (1) NO20006153L (no)
PL (1) PL345334A1 (no)
SK (1) SK17892000A3 (no)
TR (1) TR200003624T2 (no)
WO (1) WO1999064572A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921567A1 (de) 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
AU779689B2 (en) 1999-06-16 2005-02-03 Icos Corporation Human poly(ADP-ribose) polymerase 2 materials and methods
US7041675B2 (en) 2000-02-01 2006-05-09 Abbott Gmbh & Co. Kg Heterocyclic compounds and their use as PARP inhibitors
RU2447889C2 (ru) 2005-07-18 2012-04-20 Бипар Сайенсиз, Инк. Способ лечения рака (варианты)
CA2662337A1 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
CN101522609A (zh) 2006-09-05 2009-09-02 彼帕科学公司 癌症的治疗
JP2011503111A (ja) 2007-11-12 2011-01-27 バイパー サイエンシズ,インコーポレイティド Parp阻害剤単独又は抗腫瘍剤との組み合わせによる乳がんの治療
AR084894A1 (es) 2011-02-18 2013-07-10 Danisco Composicion de aditivo para pienso
GB201102865D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201102857D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201213801D0 (en) 2012-08-03 2012-09-12 Dupont Nutrition Biosci Aps Feed additive composition
DK2890780T3 (da) 2012-08-29 2020-09-21 Sangamo Therapeutics Inc Fremgangsmåder og sammensætninger til behandling af en genetisk tilstand

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162508A (en) 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
FR2707011A1 (en) 1993-06-25 1994-12-30 Pasteur Sanofi Diagnostics Immunological process for the detection and assay of antibodies directed against poly(ADP-ribose) polymerase, application to diagnosis, kit for its implementation
DE4444949C1 (de) 1994-12-16 1996-11-21 Deutsches Krebsforsch Vektoren und Viren zur Gentherapie

Also Published As

Publication number Publication date
IL139750A0 (en) 2002-02-10
US7754459B1 (en) 2010-07-13
KR20010052582A (ko) 2001-06-25
EP1082416A2 (de) 2001-03-14
DE59914280D1 (en) 2007-05-10
AR020326A1 (es) 2002-05-08
BR9910967A (pt) 2001-02-13
ATE358175T1 (de) 2007-04-15
JP2002517231A (ja) 2002-06-18
BG105018A (en) 2001-12-31
CA2330206A1 (en) 1999-12-16
CN1304446A (zh) 2001-07-18
HUP0103190A2 (hu) 2001-12-28
TR200003624T2 (tr) 2001-06-21
WO1999064572A3 (de) 2000-06-08
US20160010067A1 (en) 2016-01-14
HK1038591A1 (zh) 2002-03-22
NO20006153D0 (no) 2000-12-04
CO5070700A1 (es) 2001-08-28
CA2330206C (en) 2010-04-13
PL345334A1 (en) 2001-12-17
EP1082416B1 (de) 2007-03-28
ID27819A (id) 2001-04-26
NO20006153L (no) 2001-02-02
US9051553B2 (en) 2015-06-09
HRP20010013A2 (en) 2001-12-31
US20110107444A1 (en) 2011-05-05
AU4605999A (en) 1999-12-30
ES2285842T3 (es) 2007-11-16
WO1999064572A2 (de) 1999-12-16

Similar Documents

Publication Publication Date Title
US9051553B2 (en) Poly(ADP-ribose) polymerase genes
AU2001284483B2 (en) Remedies for heart failure
KR100728405B1 (ko) Nogo 유전자의 뉴클레오티드와 단백질 서열 및 이들에기초한 방법
US7485697B2 (en) Soluble rage protein
Simbürger et al. Expression of connexin43 mRNA in adult rodent brain
US7148002B2 (en) Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
WO2003061681A2 (en) Proteins involved in the regulation of energy homeostasis and organelle metabolism
KR20080028888A (ko) 신규 생리 물질 nesfatin과 그 관련 물질, 및그들의 용도
US20030203464A1 (en) Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
JP2002520007A (ja) Delta切断産物およびそれに基づく方法
KR20060036119A (ko) 시노비올린 활성 조절 작용의 검출 방법
ZA200100084B (en) Poly(ADP-ribose)polymerase gene.
CZ20004536A3 (cs) Nové poly(ADP-ribóza) polymerázové geny
JPH08502487A (ja) 新規なクラスのrptpアーゼ:それらの構造ドメイン及びリガンド
MXPA00011567A (en) Poly(adp-ribose)polymerase gene
US7083935B2 (en) Androgen receptor complex-associated protein
KR101145348B1 (ko) 퇴행성 관절염과 관련된 유전자 및 그의 용도
JP4488720B2 (ja) アポトーシス関連蛋白質およびその用途
JP4175680B2 (ja) 新規タンパク質およびそのdna
CN101312987A (zh) 融合蛋白用于预防或治疗由局部缺血引起的病状的用途
WO2006101273A1 (ja) 癌の予防・治療剤
US20050095594A1 (en) Nucleic acid sequences of hyperplasies and tumors of the thyroid
WO2004030688A1 (ja) 蛋白間相互作用を調節することによる新規アポトーシス調節方法と、それを用いる医薬
WO2004002513A2 (en) Proteins involved in the regulation of energy homeostasis